Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1

Conditions

Breast Neoplasms 4Peripheral Nervous System Diseases 2

Interventions

Paclitaxel 3Acupuncture Therapy 3Glutamine 2Fatty Acids, Omega-3 2Cryotherapy 2eribulin 1Yoga 1Vitamin D 1Vitamin B 6 1Vitamin B 12 1Thioctic Acid 1Taxoids 1Surveys and Questionnaires 1Sugars 1Sodium Chloride 1Silymarin 1Saline Solution 1Physical Therapy Modalities 1Pentoxifylline 1Omacor 1Minocycline 1Methods 1Metformin 1Massage 1Magnetic Resonance Spectroscopy 1Losartan 1Lidocaine 1Hydroxychloroquine 1Fumigant 93 1Fish Oils 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Peripheral Nervous System Diseases × Glutamine × Breast × Clear all
NCT00195013 2018-06-06

Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy

Weill Medical College of Cornell University

Phase 3 Completed
30 enrolled 5 charts
Breast

Breast Neoplasms, Peripheral Nervous System Diseases

NCT02215083 2017-07-12

L-glutamine Supplementation to Alleviate Symptoms of Taxane-Induced Neuropathy in Patients With Breast Cancer

Eastern Regional Medical Center

Phase 1 Withdrawn
Breast

Breast Neoplasms, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡